Cost-effectiveness analysis of trastuzumab emtansine (T-DM1) in treating HER-2 positive advanced breast cancer in Taiwan

Lin Chien Wang, Chun Nan Kuo, Yu Ko

Research output: Contribution to journalComment/debate

Original languageEnglish
JournalBreast Journal
DOIs
Publication statusAccepted/In press - 2020

Keywords

  • cost-effectiveness analysis
  • metastatic breast cancer
  • T-DM1

ASJC Scopus subject areas

  • Internal Medicine
  • Surgery
  • Oncology

Cite this